(Q37635008)

21 August 2017

1 reference

title

Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease? (English)

1 reference

inflammatory bowel diseases

21 August 2017

main subject

0 references

inflammation

0 references

author name string

Linda A Feagins

series ordinal

1

1 reference

21 August 2017

Byron L Cryer

series ordinal

2

1 reference

21 August 2017

publication date

1 February 2010

1 reference

Digestive Diseases and Sciences

21 August 2017

published in

1 reference

21 August 2017

volume

55

1 reference

21 August 2017

issue

2

1 reference

21 August 2017

page(s)

226-232

1 reference

STAT3 and NF-kappaB signal pathway is required for IL-23-mediated IL-17 production in spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice

21 August 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1042-7

Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-009-1042-7

Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

21 January 2018

1 reference

12 December 2020

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

12 December 2020

Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis

1 reference

12 December 2020

The spectrum of gastrointestinal toxicity and effect on disease activity of selective cyclooxygenase-2 inhibitors in patients with inflammatory bowel disease.

1 reference

12 December 2020

NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.

1 reference

12 December 2020

Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID-enteropathy in the rat.

1 reference

12 December 2020

Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study

1 reference

12 December 2020

Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial

1 reference

12 December 2020

Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies

1 reference

12 December 2020

Eicosanoids and the gastrointestinal tract

1 reference

12 December 2020

Gastric mucosal defense and cytoprotection: bench to bedside

1 reference

12 December 2020

Why do patients with ulcerative colitis relapse?

1 reference

12 December 2020

Role of intestinal mucins in innate host defense mechanisms against pathogens

1 reference

12 December 2020

Management of Crohn's disease in adults.

1 reference

12 December 2020

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

1 reference

12 December 2020

Cyclooxygenase-independent actions of cyclooxygenase inhibitors

1 reference

12 December 2020

Phorbol ester treatment increases paracellular permeability across IEC-18 gastrointestinal epithelium in vitro.

1 reference

12 December 2020

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

1 reference

12 December 2020

Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?

1 reference

12 December 2020

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia

1 reference

12 December 2020

In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis

1 reference

12 December 2020

Unravelling the pathogenesis of inflammatory bowel disease

1 reference

12 December 2020

Nonsteroidal antiinflammatory drugs and the small intestine

1 reference

12 December 2020

Drug-induced injury in the gastrointestinal tract: clinical and pathologic considerations

1 reference

12 December 2020

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease

1 reference

12 December 2020

Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS)-induced colon lesions in rats

1 reference

12 December 2020

Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease

1 reference

12 December 2020

Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease

1 reference

12 December 2020

A long-term cohort study of nonsteroidal anti-inflammatory drug use and disease activity in outpatients with inflammatory bowel disease

1 reference

12 December 2020

Sustained release and enteric coated NSAIDs: are they really GI safe?

1 reference

12 December 2020

Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders

1 reference

12 December 2020

Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention

1 reference

12 December 2020

Analgesic ingestion and other factors preceding relapse in ulcerative colitis

1 reference

12 December 2020

A trial of zileuton versus mesalazine or placebo in the maintenance of remission of ulcerative colitis. The European Zileuton Study Group For Ulcerative Colitis

1 reference

12 December 2020

Relapse of inflammatory bowel disease associated with use of nonsteroidal anti-inflammatory drugs

1 reference

12 December 2020

10.1007/S10620-009-1042-7

Identifiers

DOI

1 reference

21 August 2017

1 reference